Position in ATEC
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$3,684
-$2,822 QoQ
Shares Held
426
-28.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#246
of 265 holders
Holding Since
Jun 2021
12 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ATEC Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Parallel Advisors, LLC holds $27,350,929 across 59 Medical Devices names. ATEC ranks #44 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
29,358 | $9,243,072 | |
| 2 | ABT |
Abbott Laboratories
|
97,529 | $8,849,781 | |
| 3 | EW |
Edwards Lifesciences Corp
|
49,120 | $4,443,395 | |
| 4 | MDT |
Medtronic plc
|
19,868 | $1,554,273 | |
| 5 | BSX |
Boston Scientific Corp
|
15,338 | $654,625 | |
| 6 | SGHT |
Sight Sciences, Inc.
|
64,395 | $349,020 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
4,246 | $271,786 | |
| 8 | DXCM |
Dexcom Inc
|
3,307 | $222,726 |
All Filings in ATEC
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,684 | 426 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $6,506 | 598 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $7,048 | 335 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $4,870 | 335 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,718 | 335 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $4,350 | 429 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $2,946 | 321 | Shares | Sole | 2025-02-10 | |
| 2024-06-30 | $1,797 | 172 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $3,750 | 272 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $2,598 | 172 | Shares | Sole | 2024-02-12 | |
| 2021-12-31 | $148 | 13 | Shares | Sole | 2022-01-20 | |
| 2021-06-30 | $934 | 61 | Shares | Sole | 2021-08-06 | |
| No filing history on record for this holder in this stock. | ||||||